Cyteir Therapeutics Raises Additional $40.2M in Series B Financing
Cyteir Therapeutics, a Lexington, Mass.-based leader in the discovery and development of next-generation synthetic lethal therapies for cancer, closed an additional $40.2m in Series B financing, for a...
View ArticleArsenalBio Raises $85M in Series A Financing
ArsenalBio, a South San Francisco, Calif.-based programmable cell therapy company, raised $85m in Series A financing. Investors included Westlake Village BioPartners, the Parker Institute for Cancer...
View ArticleIonQ Raises $55M in Funding
IonQ, a College Park, MD-based quantum computing company, raised $55m in funding. The round was led by Samsung Catalyst and Mubadala, with participation from ACME Capital, Airbus Ventures, Hewlett...
View ArticleSiFive Raises $61M in Series E Funding
SiFive, Inc., a San Mateo, Calif.-based provider of commercial RISC-V processor IP and silicon solutions, raised $61m in Series E funding. The round was led by SK hynix, with participation from new...
View ArticleQ32 Bio Raises $60M in Series B Financing
Q32 Bio, a Cambridge, Mass.-based biotechnology company developing biologic therapeutics to restore healthy immune regulation, closed a $60m Series B financing. The round was co-led by OrbiMed Advisors...
View ArticleAtsena Therapeutics Raises $55M in Series A Financing
Atsena Therapeutics, a Durham, N.C. and Boston, MA-based clinical-stage gene therapy company, closed a $55m Series A financing. The round was led by Sofinnova Investments with participation from...
View ArticleDiCE Molecules Raises $80M in Series C Financing
DiCE Molecules, a South San Francisco, Calif.-based biopharmaceutical company leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in immunology,...
View ArticleNeuros Medical Raises $38.5M in Series BB Funding
Neuros Medical, Inc., a Willoughby Hills, OH-based medical device company developing innovative high-frequency nerve block technology for patients with intractable post-amputation pain, closed a Series...
View ArticleeGenesis Raises $125M in Series C Financing
eGenesis, a Cambridge, Mass.-based gene-editing and genome-engineering company developing human-compatible organs, tissues, and cells, completed a $125m Series C financing. Backers included Farallon...
View ArticleFortis Therapeutics Raises $40M in Series A Funding
Fortis Therapeutics, Inc., a San Diego, CA-based immuno-oncology biotech company, closed a $40m Series A financing. Backers included Avalon Ventures, Bregua Corporation, Lilly Asia Ventures, Osage...
View ArticleHack The Box Raises $10.6M in Series A Funding
Hack The Box, a UK-based provider of an ethical hacking community and cybersecurity training platform, raised $10.6M in Series A funding. The round was led by Paladin Capital Group with participation...
View ArticleInterius BioTherapeutics Raises $76M in Series A Financing
Interius BioTherapeutics, a Philadelphia, PA-based preclinical stage gene therapy company developing a paradigm-shifting platform for in vivo cell-specific gene delivery, raised $76m in Series A...
View ArticleRibon Therapeutics Raises $65M in Funding
Ribon Therapeutics, a Cambridge, Mass.-based clinical stage biotechnology company developing therapeutics targeting stress support pathways in cancer and inflammation, closed a $65m financing. The...
View ArticleDiCE Molecules Raises $60M in Series C-1 Financing
DiCE Molecules, a San Francisco, CA-based biopharmaceutical company leveraging its proprietary DNA-encoded library platform to discover and develop next-generation therapeutics in immunology and other...
View ArticleCorelight Raises $75M in Series D Funding
Corelight, a San Francisco CA-based open network detection and response (NDR) platform provider, raised $75M in Series D funding. The round was led by Energy Impact Partners with participation from...
View ArticleMicroTransponder Raises $53M in Series E Funding
MicroTransponder, an Austin, TX-based medical device company, raised $53M in Series E funding. Backers included US Venture Partners, GPG Ventures, Exceller Hunt Ventures, Osage University Partners,...
View ArticleNikola Labs Raises Additional $9M in Series A
Nikola Labs, a Columbus, OH-based provider of sensor-based reliability solutions that monitor the health of critical manufacturing equipment, raised an additional $9m in Series A funding. The...
View ArticleDelfi Diagnostics Raises $225M in Series B Financing
Delfi Diagnostics, Inc., a Palo Alto, CA- and Baltimore, MD-based developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection and monitoring, raised USD225m...
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View Article--- Article Not Found! ---
*** *** *** RSSing Note: Article is missing! We don't know where we put it!!. *** ***
View ArticleOpsys Tech Closes $51.5M Series C Financing
Opsys Tech, a Holon, Israel-based developer of patented True Solid-State Scanning LiDAR technology, raised additional $36.5M in Series C funding. The final closing brought the total amount raised in...
View ArticleHack The Box Raises $55M in Series B Funding
Hack The Box, a Folkestone, Kent, UK-based provider of a gamified continuous cybersecurity platform, raised $55M in Series B funding. The round was led by Carlyle, Paladin Capital Group, Osage...
View ArticleChroma Medicine Raises $135M in Series B Financing
Chroma Medicine, a Cambridge, MA-based genomic medicine company, raised $135M in Series B funding. The round was led by GV, with participation from additional new investors ARCH Venture Partners, DCVC...
View ArticleKate Therapeutics Raises $51M in Series A Funding
Kate Therapeutics, a San Diego, CA-based gene therapy company, raised $51M in Series A funding. The round was led by Westlake Village BioPartners and Versant Ventures with participation from Osage...
View ArticleReCode Therapeutics Raises Additional USD50M in Series B Financing
ReCode Therapeutics, a Menlo Park, CA-based clinical-stage genetic medicines company using precision delivery mRNA and gene correction therapeutics, closed an extension to its Series B financing,...
View ArticlePrecede Biosciences Emerges From Stealth With $57M in Funding
Precede Biosciences, a Boston, MA-based biotechnology company providing a blood-based approach to revealing disease-defining transcriptional biology, emerged from stealth with $57M in funding since...
View ArticleBioAge Labs Raises $170M in Series D Financing
BioAge Labs, a Richmond, CA-based clinical-stage biotechnology company developing novel therapies for obesity and metabolic diseases by harnessing the biology of aging, raised $170M in Series D...
View ArticleNocion Therapeutics Raises $62M in Series B Financing
Nocion Therapeutics, a Watertown, MA-based clinical-stage biopharmaceutical company, raised $62M in Series B funding. The round, which brought the total amount to $122M, was led by Arkin Bio Capital...
View ArticleQuintessent Raises $11.5M in Seed Funding
Quintessent, a Santa Barbara, CA-based heterogeneous silicon photonics and quantum dot laser technology company, closed on over $11.5m in Seed funding round. Osage University Partners (OUP) led the...
View Article
